相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repurposing of Prochlorperazine for Use Against Dengue Virus Infection
Yogy Simanjuntak et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Novel Cell-Based Hepatitis C Virus Infection Assay for Quantitative High-Throughput Screening of Anti-Hepatitis C Virus Compounds
Zongyi Hu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus
Ana M. Chamoun-Emanuelli et al.
ANTIVIRAL RESEARCH (2014)
Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity
Siwaporn Boonyasuppayakorn et al.
ANTIVIRAL RESEARCH (2014)
Anti-Dengue-Virus Activity and Structure-Activity Relationship Studies of Lycorine Derivatives
Peng Wang et al.
CHEMMEDCHEM (2014)
Determining the Involvement and Therapeutic Implications of Host Cellular Factors in Hepatitis C Virus Cell-to-Cell Spread
Naina Barretto et al.
JOURNAL OF VIROLOGY (2014)
Hepatitis C drugs not reaching poor
Ewen Callaway
NATURE (2014)
Phenothiazines Inhibit Hepatitis C Virus Entry, Likely by Increasing the Fluidity of Cholesterol-Rich Membranes
Ana M. Chamoun-Emanuelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Antimalarial Ferroquine Is An Inhibitor of Hepatitis C Virus
Thibaut Vausselin et al.
HEPATOLOGY (2013)
Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly
Qisheng Li et al.
NATURE MEDICINE (2013)
Global control of hepatitis C: where challenge meets opportunity
David L. Thomas
NATURE MEDICINE (2013)
Current progress in development of hepatitis C virus vaccines
T. Jake Liang
NATURE MEDICINE (2013)
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Troels K. H. Scheel et al.
NATURE MEDICINE (2013)
Current and Future Therapies for Hepatitis C Virus Infection
T. Jake Liang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
Jeremie Guedj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein
Joshua A. Horwitz et al.
VIROLOGY (2013)
Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention
Bryce D. Smith et al.
ANNALS OF INTERNAL MEDICINE (2012)
Identification of Hepatitis C Virus Inhibitors Targeting Different Aspects of Infection Using a Cell-Based Assay
Xuemei Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding
Shufeng Liu et al.
HEPATOLOGY (2012)
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
Bruno Sainz et al.
NATURE MEDICINE (2012)
Histamine and H1-antihistamines: Celebrating a century of progress
F. Estelle R. Simons et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo
Hiromi Abe et al.
JOURNAL OF HEPATOLOGY (2011)
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Joachim Lupberger et al.
NATURE MEDICINE (2011)
Mining for therapeutic gold
Francis S. Collins
NATURE REVIEWS DRUG DISCOVERY (2011)
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
Ruili Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Discovery of a β-D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
Michael J. Sofia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Exploiting Drug Repositioning for Discovery of a Novel HIV Combination Therapy
Christine L. Clouser et al.
JOURNAL OF VIROLOGY (2010)
Production of Infectious Hepatitis C Virus by Using RNA Polymerase I-Mediated Transcription
Takahiro Masaki et al.
JOURNAL OF VIROLOGY (2010)
Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection
Pablo Gastaminza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
Karuppiah Chockalingam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development and Characterization of Hepatitis C Virus Genotype 1-7 Cell Culture Systems: Role of CD81 and Scavenger Receptor Class B Type I and Effect of Antiviral Drugs
Judith M. Gottwein et al.
HEPATOLOGY (2009)
Mouse models for the study of HCV infection and virus-host interactions
Heidi Barth et al.
JOURNAL OF HEPATOLOGY (2008)
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis
Shirit Einav et al.
NATURE BIOTECHNOLOGY (2008)
Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus
Christopher T. Jones et al.
JOURNAL OF VIROLOGY (2007)
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
James Inglese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application
Norman M. Kneteman et al.
HEPATOLOGY (2006)
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
M Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
K Watashi et al.
HEPATOLOGY (2003)
Biotransformation of cyclizine in greyhounds. 1: identification and analysis of cyclizine and some basic metabolites in canine urine by gas chromatography-mass spectrometry
MC Dumasia et al.
XENOBIOTICA (2002)
Screening for anti-HIV drugs that can combine virucidal and virustatic activities synergistically
AN Chakrabarty et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
分享论文
